Protective immune cells that are recruited in response to chronic inflammation, such as T helper -2 (Th-2), tend to enhance the function of pro-tumor adaptive pathways such as ICIs PD-1/PD-L1 and CTLA-4 [93]. The gene discussed is CD274; the disease is neoplasm.